Oscar Health Inc. (OSCR) Misses Q2 EPS by 5c; maintaing guidance

Oscar Health Inc. (NYSE: OSCR) reported Q2 EPS of ($0.89), $0.05 worse than the analyst estimate of ($0.84). Revenue for the quarter came in at $2.86 billion versus the consensus estimate of $2.92 billion.

GUIDANCE:

Oscar Health Inc. sees FY2025 revenue of $12-12.2 billion, versus the consensus of $12.01 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.

You May Also Be Interested In

• Occidental Petroleum releases Q2 2026 earnings considerations
• What Delta’s report tells investors in American and United
• Cognizant shareholder derivative settlement gets preliminary approval